Akexis is a biotechnology company dedicated to developing transformative cancer therapeutics. Led by a team of seasoned scientists, clinicians, and innovators, Akexis is committed to advancing solutions that address the highly unmet needs of late-stage cancer patients. Our vision is to revolutionize late-stage cancer by pushing boundaries and transforming it from a terminal disease to a manageable and curable condition. Through innovative approaches and tailored treatments, we aim to empower patients with new possibilities for long-term remission and improved quality of life.
Company Details
- Employees
- 3
- Founded
- 2025
- Address
- 9901 Brodie Ln, Austin,texas 78748,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.akexis.com/
- Keywords
- ADJUVA BIO.
- HQ
- Austin, Texas
Akexis Questions
Akexis's website is https://www.akexis.com/
Akexis's LinkedIn profile is https://www.linkedin.com/company/akexis
Akexis has
3 employees.
View email and phone details for 3
employees at Akexis.
Akexis's industry is
Biotechnology Research
Akexis's top competitors are
Benji's Buns - New York,
Jt Biopharma Partners,
Girl-Science,
Adjuva Bio,
Diligo Intelligence,
Angiowave Imaging,
Eat Fresh,
Cavea Technologies,
Viuhealth,
Impresa Advisors Llc.
Akexis's categories are Biotechnology Research
Akexis's founding year is 2025
